Chee Kong Choo
Director at CytoMed Therapeutics Ltd (GDTC)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-25.9%
vs. S&P 500-27.0%
Beat the market0%
Paper profit on buys−$273K
Total bought / sold$729K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 24SEC | GDTCCytoMed Therapeutics Ltd | Buy | 100,000530,324 held (+23%) | $1.50 | $150K | -40.7% |
| Jul 24SEC | GDTCCytoMed Therapeutics Ltd | Buy | 100,000630,324 held (+19%) | $1.50 | $150K | -40.7% |
| Jul 24SEC | GDTCCytoMed Therapeutics Ltd | Buy | 100,000530,324 held (+23%) | $1.50 | $150K | -40.7% |
| Jul 24SEC | GDTCCytoMed Therapeutics Ltd | Buy | 100,000630,324 held (+19%) | $1.50 | $150K | -40.7% |
| Jun 15SEC | GDTCCytoMed Therapeutics Ltd | Buy | 112,000430,324 held (+35%) | $1.15 | $129K | -22.6% |
- Buy
Director Chee Kong Choo bought $150K of GDTC at $1.50 — largest purchase by this insider in our records; raises the stake by 23%.
- Buy
Director Chee Kong Choo bought $150K of GDTC at $1.50 — raises the stake by 23%.
- Buy
Director Chee Kong Choo bought $129K of GDTC at $1.15 — first open-market purchase in our records; raises the stake by 35%.